139 related articles for article (PubMed ID: 3657707)
1. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: experience of the Münster/Kassel Group.
Fischer M; Wehinger H; Kraus C; Ritter J; Schröter W
Med Pediatr Oncol; 1987; 15(4):196-8. PubMed ID: 3657707
[TBL] [Abstract][Full Text] [Related]
2. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: the experience of an Italian Study Group.
Bestagno M; Guerra P; Puricelli GP; Colombo L; Calculli G
Med Pediatr Oncol; 1987; 15(4):203-4. PubMed ID: 3657708
[TBL] [Abstract][Full Text] [Related]
3. Considerations on 131I-metaiodobenzylguanidine therapy of six children with neuroblastoma.
Sanguineti M
Med Pediatr Oncol; 1987; 15(4):212-5. PubMed ID: 3657710
[TBL] [Abstract][Full Text] [Related]
4. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
Troncone L; Riccardi R; Montemaggi P; Rufini V; Lasorella A; Mastrangelo R
Med Pediatr Oncol; 1987; 15(4):220-3. PubMed ID: 3657712
[TBL] [Abstract][Full Text] [Related]
5. Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
Treuner J; Klingebiel T; Feine U; Buck J; Bruchelt G; Dopfer R; Girgert R; Müller-Schauenburg W; Meinke J; Kaiser W
Pediatr Hematol Oncol; 1986; 3(3):205-16. PubMed ID: 2484676
[TBL] [Abstract][Full Text] [Related]
6. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
7. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
[No Abstract] [Full Text] [Related]
8. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of 131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patients.
Hartmann O; Lumbroso J; Lemerle J; Schlumberger M; Ricard M; Aubert B; Coonaert S; Merline L; Olive D; De Lumley L
Med Pediatr Oncol; 1987; 15(4):205-11. PubMed ID: 3657709
[TBL] [Abstract][Full Text] [Related]
10. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.
Klingebiel T; Feine U; Treuner J; Reuland P; Handgretinger R; Niethammer D
J Nucl Biol Med (1991); 1991; 35(4):216-9. PubMed ID: 1823821
[TBL] [Abstract][Full Text] [Related]
11. [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].
Klingebiel T; Feine U; Niethammer D; Müller-Schauenburg W; Schwabe D; Maul FD; Gerein V; Fischer M; Gahr M; Kraz K
Klin Padiatr; 1986; 198(3):230-6. PubMed ID: 3723987
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
Parisi MT; Matthay KK; Huberty JP; Hattner RS
Radiology; 1992 Aug; 184(2):463-7. PubMed ID: 1620849
[TBL] [Abstract][Full Text] [Related]
13. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
14. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
[TBL] [Abstract][Full Text] [Related]
15. Treatment of neuroblastoma with metaiodobenzylguanidine: results and side effects.
Treuner J; Klingebiel T; Bruchelt G; Feine U; Niethammer D
Med Pediatr Oncol; 1987; 15(4):199-202. PubMed ID: 3309604
[TBL] [Abstract][Full Text] [Related]
16. Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.
Klingebiel T; Berthold F; Treuner J; Schwabe D; Fischer M; Feine U; Maul FD; Waters W; Wehinger H; Niethammer D
Med Pediatr Oncol; 1991; 19(2):84-8. PubMed ID: 2011100
[TBL] [Abstract][Full Text] [Related]
17. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
Fischer M
Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
[TBL] [Abstract][Full Text] [Related]
18. Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after.
Hör G; Maul FD; Kornhuber B; Schwabe D; Hesse J; Manegold KH; Baüm RP; Gerein V
J Nucl Biol Med (1991); 1991; 35(4):207-15. PubMed ID: 1823820
[TBL] [Abstract][Full Text] [Related]
19. 131I-metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis.
Mastrangelo R; Troncone L; Lasorella A; Riccardi R; Montemaggi P; Rufini V
Am J Pediatr Hematol Oncol; 1989; 11(1):28-31. PubMed ID: 2785352
[TBL] [Abstract][Full Text] [Related]
20. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
